| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/16/2013 | US8486924 Taxane delivery system |
| 07/16/2013 | US8486923 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 07/16/2013 | US8486891 Nasal calcitonin formulations containing chlorobutanol |
| 07/16/2013 | US8486464 Herbal composition for angina pectoris, method to prepare same and uses thereof |
| 07/16/2013 | US8486458 Methods and compositions for extracting flavor and fragrance compounds and solubilizing essential oils |
| 07/16/2013 | US8486455 Polymeric delivery formulations of leuprolide with improved efficacy |
| 07/16/2013 | US8486443 UV stable transdermal therapeutic plaster with a UV absorbing adhesive layer separated from the drug matrix |
| 07/16/2013 | US8486441 Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue |
| 07/16/2013 | US8486439 Parenteral formulation |
| 07/16/2013 | US8486432 Method of treating animal's exterior for cleaning and/or insect repellency |
| 07/16/2013 | US8486391 Cancer treatment kits using antibodies to aminophospholipids |
| 07/16/2013 | US8486374 Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| 07/16/2013 | US8486373 Intramolecularly-quenched near infrared fluorescent probes |
| 07/16/2013 | CA2738715C Highly concentrated drug particles, formulations, suspensions and uses thereof |
| 07/16/2013 | CA2707067C Clear ophthalmic solution comprising latanoprost as active ingredient |
| 07/16/2013 | CA2650056C Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
| 07/16/2013 | CA2631335C Four branched dendrimer-peg for conjugation to proteins and peptides |
| 07/16/2013 | CA2620026C Method for production of single- and multi-layer microcapsules |
| 07/16/2013 | CA2558582C Stabilised supersaturated solids of lipophilic drugs |
| 07/16/2013 | CA2551121C Crosslinked hyaluronic acid compositions for tissue augmentation |
| 07/16/2013 | CA2549115C Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
| 07/16/2013 | CA2526007C Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 07/16/2013 | CA2512138C Kim-1 antagonists and use to modulate immune system |
| 07/16/2013 | CA2483980C Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 07/16/2013 | CA2483120C Polymeric adhesive transdermal patch comprising rotigotine for treatment of restless leg syndrome |
| 07/16/2013 | CA2464656C Spray drying methods and compositions thereof |
| 07/16/2013 | CA2448348C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/16/2013 | CA2445281C Prevention of myocardial infarction induced ventricular expansion and remodeling |
| 07/16/2013 | CA2289742C Method for generating activated t-cells and antigen-pulsed antigen-presenting cells |
| 07/16/2013 | CA2226624C Methods for treatment of allergic asthma |
| 07/15/2013 | CA2818075A1 Reducible self-assembled micelle drug delivery systems |
| 07/11/2013 | WO2013103771A1 Cellulose ethers with improved thermal gel strength |
| 07/11/2013 | WO2013103707A1 Ligand-targeted molecules and methods thereof |
| 07/11/2013 | WO2013103688A1 Human soluble receptors for advanced glycation end products (srage), methods of preparing human srage, and treatment methods using srage |
| 07/11/2013 | WO2013103614A1 Crlf-2 binding peptides, protocells and viral-like particles useful in the treatment of cancer, including acute lymphoblastic leukemia (all) |
| 07/11/2013 | WO2013103424A2 Silk-based multifunctional biomedical platform |
| 07/11/2013 | WO2013103301A2 Method for preparing cell targeting conjugates, and the complexes obtained |
| 07/11/2013 | WO2013103297A1 Polyoxazoline polymers and methods for their preparation, conjugates of these polymers and medical uses thereof |
| 07/11/2013 | WO2013103106A1 Sugar composition mainly composed of sucrose and d-psicose, and method for producing same |
| 07/11/2013 | WO2013102885A1 Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
| 07/11/2013 | WO2013102742A1 Liquid solution comprising peba |
| 07/11/2013 | WO2013102265A1 Compositions and methods for treating multiple sclerosis |
| 07/11/2013 | WO2013102264A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
| 07/11/2013 | WO2013087808A8 Pharmaceutical composition comprising a pyrazolopyrimidine and cyclodextrin |
| 07/11/2013 | WO2013020136A3 Treatment of traumatic brain injury |
| 07/11/2013 | WO2013019681A3 Selective delivery molecules and methods of use |
| 07/11/2013 | WO2012177837A3 Novel maytansinoid derivatives with peptide linker and conjugates thereof |
| 07/11/2013 | WO2012085523A3 Skin sanitizer compositions comprising alcohol based emulsion |
| 07/11/2013 | WO2011163012A3 Amide based glucagon superfamily peptide prodrugs |
| 07/11/2013 | US20130178541 Novel low molecular weight cationic lipids for oligonucleotide delivery |
| 07/11/2013 | US20130178538 Long-Acting Injectable Analgesic Formulations for Animals |
| 07/11/2013 | US20130178535 Acetaminophen Composition |
| 07/11/2013 | US20130178524 Prostaglandin-containing product |
| 07/11/2013 | US20130178467 Highly concentrated stable meloxicam solutions |
| 07/11/2013 | US20130178463 Enhanced transbuccal drug delivery system and compositions |
| 07/11/2013 | US20130178448 Treatment of Respiratory Disorders |
| 07/11/2013 | US20130178422 Sparc and methods of use thereof |
| 07/11/2013 | US20130178421 Interfering rna delivery system and uses thereof |
| 07/11/2013 | US20130178415 Injectable solution at pH 7 comprising at least one basal insulin the PI of which is between 5.8 and 8.5 and a substituted co-polyamino acid |
| 07/11/2013 | US20130178411 Therapeutic agents comprising elastic peptides |
| 07/11/2013 | US20130177961 Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| 07/11/2013 | US20130177651 Pharmaceutical Composition Suitable for Use in a Dry Powder Inhaler |
| 07/11/2013 | US20130177650 Pellet formulation for the treatment of the intestinal tract |
| 07/11/2013 | US20130177648 Collagen/hydroxyapatite composite scaffold, and process for the production thereof |
| 07/11/2013 | US20130177631 Method and medicament for inhibiting the expression of a given gene |
| 07/11/2013 | US20130177619 Vitamin powder composition and method of making |
| 07/11/2013 | US20130177613 Packaging assembly for pharmaceutical composition including pimobendan |
| 07/11/2013 | US20130177611 Silk-based drug delivery system |
| 07/11/2013 | US20130177594 Pharmaceutical composition and method for producing the same |
| 07/11/2013 | US20130177588 Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine |
| 07/11/2013 | US20130177569 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer |
| 07/11/2013 | US20130177532 PEGylation by the Dock and Lock (DNL) Technique |
| 07/11/2013 | US20130177526 Camptothecin Conjugates of Anti-CD22 Antibodies for Treatment of B Cell Diseases |
| 07/11/2013 | US20130177522 Non-irritating opthalmic povidone-iodine compositions |
| 07/11/2013 | US20130177521 Subcutaneous Delivery of Poly(oxazoline) Conjugates |
| 07/11/2013 | US20130177520 Taste masked dosage forms of bitter tasting anti-retroviral drugs |
| 07/11/2013 | US20130177499 Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors |
| 07/11/2013 | CA2801319A1 Pharmaceutical composition and method for producing the same |
| 07/10/2013 | EP2612914A1 Oligonucleotide, and therapeutic agent for dyslipidemia containing oligonucleotide as active ingredient |
| 07/10/2013 | EP2612857A1 Chemical synthesis and anti-tumor and anti-metastatic effects of dual functional conjugate |
| 07/10/2013 | EP2612703A2 Particulate materials |
| 07/10/2013 | EP2612682A2 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| 07/10/2013 | EP2612681A1 Coating agent for pharmaceutical solid preparation, pharmaceutical film formulation, and coated pharmaceutical solid preparation |
| 07/10/2013 | EP2612677A1 Preparation comprising insulin, nicotinamide and an amino acid |
| 07/10/2013 | EP2612674A1 Freeze-dried recombinant human bone morphogenetic protein-2 preparation |
| 07/10/2013 | EP2612671A1 A clinical preparation of scutellarin and the preparation method thereof |
| 07/10/2013 | EP2612665A1 Topical pharmaceutical compositions comprising bexarotene and a corticosteroide |
| 07/10/2013 | EP2612664A1 Stabilized polyphenol solution and method for stabilizing polyphenol solution |
| 07/10/2013 | EP2612657A1 Orally disintegrating tablet |
| 07/10/2013 | EP2612656A1 Process for producing drug block-copolymer composite and pharmaceutical product containing same |
| 07/10/2013 | EP2612655A1 Liquid compositions of insoluble drugs and preparation methods thereof |
| 07/10/2013 | EP2612629A1 Compositions for transdermal oxybutynin therapy |
| 07/10/2013 | EP2611928A1 Anti-c-met antibody and methods of use thereof |
| 07/10/2013 | EP2611822A2 Compositions for labeling nerves and methods of use |
| 07/10/2013 | EP2611818A2 Phosphonate ester derivatives and methods of synthesis thereof |
| 07/10/2013 | EP2611477A2 Hemostatic compositions and methods of making and using same |
| 07/10/2013 | EP2611466A2 Shear controlled release for stenotic lesions and thrombolytic therapies |
| 07/10/2013 | EP2611442A2 Drug formulations using water soluble antioxidants |
| 07/10/2013 | EP2611426A1 Tamper resistant dosage form comprising inorganic salt |
| 07/10/2013 | EP2611419A2 Method for producing a tetranectin-apolipoprotein a-1 lipid particle, the lipid particle itself and its use |